Defunct Company
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
19
NCT01597401
A Single Dose Study of the Safety, Blood Levels and Biological Effects of Aes-103 Compared to Placebo in Subjects With Stable Sickle Cell Disease
Phase: Phase 1
Role: Collaborator
Start: May 12, 2012
Completion: Jun 7, 2013